Mexican University to Validate GeneThera Platform for Johne's Disease | GenomeWeb

NEW YORK (GenomeWeb News) – GeneThera announced today that its wholly owned subsidiary Applied Genetics has signed a deal with the Universidad National Autonoma de Mexico to validate GeneThera's platform for Johne's disease.

Under the terms of the deal, the university will validate the HerdCheck Field Collection System molecular assay in Mexico. Financial and other terms of the deal were not disclosed.

The HerdCheck technology is based on high-throughput robotics and real-time PCR.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.